BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26802143)

  • 21. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative prediction of unresectability in malignant pleural mesothelioma.
    Burt BM; Lee HS; Raghuram AC; Strange C; Mason J; Strange T; Delgado J; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2512-2520.e1. PubMed ID: 32087959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
    Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
    Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
    Lim JH; Choi JY; Im Y; Yoo H; Jhun BW; Jeong BH; Park HY; Lee K; Kim H; Kwon OJ; Han J; Ahn MJ; Kim J; Um SW
    PLoS One; 2020; 15(2):e0229299. PubMed ID: 32069313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.
    Bölükbas S; Eberlein M; Kudelin N; Demes M; Stallmann S; Fisseler-Eckhoff A; Schirren J
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):119-23. PubMed ID: 23242984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
    Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
    Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
    Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
    Sugarbaker DJ; Richards WG; Bueno R
    Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
    Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
    Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
    Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.
    Sharkey AJ; Tenconi S; Nakas A; Waller DA
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1632-41. PubMed ID: 26637211
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
    Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
    Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
    Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
    Pilling J; Dartnell JA; Lang-Lazdunski L
    Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
    Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
    Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification.
    Takuwa T; Hashimoto M; Kuroda A; Nakamura A; Nakamichi T; Fukuda A; Matsumoto S; Kondo N; Hasegawa S
    Ann Surg Oncol; 2018 Jun; 25(6):1572-1579. PubMed ID: 29616420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.